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Summary
During 3 end processing, histone pre-mRNAs are
cleaved 5 nucleotides after a conserved stem loop by
an endonuclease dependent on the U7 small nuclear
ribonucleoprotein (snRNP). The upstream cleavage
product corresponds to the mature histone mRNA,
while the downstream product is degraded by a 5-3
exonuclease, also dependent on the U7 snRNP. To
identify the two nuclease activities, we carried out UV-
crosslinking studies using both the complete RNA
substrate and the downstream cleavage product, each
containing a single radioactive phosphate and a
phosphorothioate modification at the cleavage site.
We detected a protein migrating at 85 kDa that cross-
linked to each substrate in a U7-dependent manner.
Immunoprecipitation experiments identified this pro-
tein as CPSF-73, a known component of the cleavage/
polyadenylation machinery. These studies suggest
that CPSF-73 is both the endonuclease and 5-3 exo-
nuclease in histone-pre-mRNA processing and reveal
an evolutionary link between 3 end formation of his-
tone mRNAs and polyadenylated mRNAs.
Introduction
3# end processing of nuclear pre-mRNAs is an essential
step in formation of mature mRNAs. The vast majority
of pre-mRNAs undergo cleavage coupled to poly(A) ad-
dition (Zhao et al., 1999). In contrast, cleavage of meta-
zoan replication-dependent histone pre-mRNAs occurs
by a different mechanism and is not followed by poly-
adenylation (Dominski and Marzluff, 1999). Each type
of pre-mRNA contains specific sequence elements that
are recognized by a unique set of processing factors.
Histone pre-mRNAs contain two sequence elements
required for processing: (1) the stem loop consisting of
a 6 base pair stem and a 4 nucleotide loop and (2) a
histone downstream element (HDE). Cleavage occurs
between the two elements, 5 nucleotides downstream
of the stem loop. The HDE is the binding site for the U7
snRNP, which consists of an w60 nucleotide snRNA
and a number of proteins, including the U7 snRNP-spe-
cific proteins Lsm10 and Lsm11 (Schumperli and Pillai,
2004). Binding of U7 snRNP to the pre-mRNA is medi-
ated by formation of a duplex between the HDE and
the 5# end of the U7 snRNA (Birnstiel and Schaufele,
1988; Bond et al., 1991). The stem-loop binding protein
(SLBP) binds the stem loop and stabilizes the U7*Correspondence: dominski@med.unc.edusnRNP on the pre-mRNA by interacting with a compo-
nent of the U7 snRNP, ZFP100 (Dominski et al., 2002).
In processing of mammalian histone pre-mRNAs, the
cleavage site is located at a fixed distance from the
HDE, suggesting that the U7 snRNP plays a key role in
recruiting the endonuclease to the pre-mRNA (Scharl
and Steitz, 1994). A main focus of current studies is to
identify this elusive factor directly responsible for cleav-
ing histone pre-mRNAs.
Cleavage coupled to polyadenylation is carried out
by a large complex consisting exclusively of protein
factors that include the multisubunit cleavage/polyade-
nylation specificity factor (CPSF) and cleavage stimula-
tion factor (CstF) (Colgan and Manley, 1997). It is now
believed that cleavage coupled to polyadenylation is
catalyzed by CPSF-73, a subunit of CPSF (Ryan et al.,
2004). Here we report the results of UV-crosslinking
studies designed to identify proteins that contact his-
tone pre-mRNA in the vicinity of the cleavage site. We
detected an 85 kDa protein, which is crosslinked to the
histone pre-mRNA in a processing-dependent manner.
Immunoprecipitation experiments identified this protein
as CPSF-73, strongly suggesting that histone pre-
mRNAs as well as the other pre-mRNAs that undergo
cleavage/polyadenylation utilize the same endonucle-
ase during 3# end processing.
Results
In Vitro 3 End Processing of Histone pre-mRNAs
In vitro 3# end processing of histone pre-mRNAs in
mammalian nuclear extracts occurs readily in the pres-
ence of 20 mM EDTA at 32°C (Gick et al., 1986). We
routinely use the mouse histone H2A-614 pre-mRNA as
the processing substrate (Figure 1A) and nuclear ex-
tracts from mouse myeloma cells (Dominski et al.,
1999). The HDE in the H2A-614 pre-mRNA forms a sta-
ble duplex with the 5# end of the U7 snRNA consisting
of 14 base pairs interrupted by only one mismatch. As
a result of strong binding with the U7 snRNP, the H2A-
614 pre-mRNA is cleaved in vitro even in the presence
of the stem-loop RNA sequestering all SLBP (Figure 1C,
lanes 2 and 3). Processing of histone pre-mRNAs is
specifically abolished by a 2#-O-methyl oligonucleo-
tide, αMa, complementary to the first 17 nucleotides of
the mouse U7 snRNA (Figures 1B and 1C, lane 4). The
U7 snRNP is present at low concentrations in the nu-
cleus, and an excess of pre-mRNA saturates the in vitro
reaction, resulting in poor processing efficiency. Addi-
tion of 10-fold excess of unlabeled pre-mRNA sub-
strate reduces processing of the labeled pre-mRNA to
10% of its initial level (Figure 1C, lane 6). Cleavage of
the H2A-614 pre-mRNA occurs after the ACCCA (Scharl
and Steitz, 1994), leaving a 3# hydroxyl group on the
upstream fragment containing the stem loop (SL) and
5# phosphate on the downstream cleavage product
(DCP) starting with CU (Figure 1A). The DCP, visible only
when the substrate is internally labeled, is degraded by
an EDTA-resistant 5#-3# exonuclease that is also de-
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38Figure 1. In Vitro 3# End Processing of Histone pre-mRNAs
(A) The sequence of the mouse H2A-614 pre-mRNA encompassing
the stem loop (SL) and the downstream cleavage product (DCP)
containing the histone downstream element (HDE) (underlined and
numbered) that base pairs with the U7 snRNA. The site of endo-
nucleolytic cleavage and the direction of exonucleolytic degrada-
tion of the DCP are indicated with arrows. The sequences of two
2#-O-methyl oligonucleotides complementary to the HDE are
shown above.
(B) The sequence of the 5# end of the mouse/human U7 snRNA
starting with the trimethyl guanosine cap (TMG) and the sequences
(written in the 3#-5# orientation) of two anti-U7 oligonucleotides
(αMa and αMb) complementary to this region. Vertical lines indicate
base pairs. The sequences of two control 2#-O-methyl oligonucleo-
tides, αDa and αDb (written in the 5#-3# orientation), complemen-
tary to the Drosophila U7 snRNA are shown below.
(C) In vitro processing of 0.1 pmol of a 5#-labeled mouse H2A-614
pre-mRNA in a nuclear extract from mouse myeloma cells (Mm NE).
The competitors used to affect processing are indicated at the top
of each lane. The numbers in parentheses indicate the amount of
the RNA competitors in pmol. FL and SL indicate the input H2A-
614 pre-mRNA and the upstream cleavage product, respectively.
(D) In vitro processing of a uniformly labeled H2A-614 pre-mRNA in
Mm NE. Arrows indicate partial degradation products of the down-
stream cleavage product (DCP) ultimately converted to mono-
nucleotides.
(E) Release of the 5# label from the DCP in Mm NE by a U7 snRNP-
dependent mechanism.
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spendent on the U7 snRNP (Walther et al., 1998). The
degradation of the DCP is often incomplete, resulting
in accumulation of a number of intermediates partially
o
g
druncated at the 5# end in addition to mononucleotides
Figure 1D, lanes 2–4, arrows). A synthetic RNA encom-
assing the DCP not protected at the 5# end by the cap
tructure is degraded in nuclear extracts by the same
ctivity, demonstrating that the endonucleolytic cleav-
ge and the 5#-3- degradation can be uncoupled (Fig-
re 1E) (Walther et al., 1998).
rocessing and UV Crosslinking Using
he Full-Length Substrate
o identify the endonuclease that cleaves histone pre-
RNAs, we carried out UV-crosslinking experiments
sing site-specifically labeled RNA substrates. We as-
umed that formation of a crosslink between the
uclease and the RNA substrate should correlate with
rocessing efficiency. To selectively abolish process-
ng, we used two 2#-O-methyl oligonucleotides, αMa
nd αMb, complementary to either 17 or 11 nucleotides
f the 5# end of the mouse U7 snRNA (Figure 1B). In
ddition to the oligonucleotides blocking the U7 snRNA,
e also used two 2#-O-methyl oligonucleotides com-
lementary to 16 (αHDEa) or 10 nucleotides (αHDEb) of
he HDE (Figure 1A). These oligonucleotides act in cis
y blocking the site of binding for U7 snRNA on the
re-mRNA and also efficiently inhibit processing. We
onsider this control as less informative than the anti-
ouse U7 snRNA oligonucleotides since formation of
duplex spanning a significant portion of the RNA sub-
trate might also affect nonspecific binding of proteins
o the substrate.
To generate a site-specifically labeled full-length pre-
RNA, a 31 nucleotide upstream fragment containing
he stem loop and followed by the ACCCA (SL) was
igated to a 5#-labeled 38 nucleotide downstream
leavage product (DCP) that contained the U7 binding
ite from the H2A-614 pre-mRNA (Figure 1A). The full-
ength RNA (FL) containing a single 32P at the cleavage
ite (Figure 2A) was gel purified, and approximately 0.1
mol (10,000 counts per minute) used for processing
n a mouse nuclear extract (Mm NE). Each processing
ample was preincubated at 32°C for 10 min, and then
he majority of the sample was UV irradiated at room
emperature, treated with RNase A, and analyzed by
DS gel electrophoresis for the formation of crosslinks.
small aliquot was incubated at 32°C for an additional
0 min, and the RNA was isolated to measure the pro-
essing efficiency in 7 M urea gels. Following process-
ng, the upstream product containing the stem loop is
ot detected by autoradiography since the radioactive
hosphate remains at the 5# end of the DCP, which is
egraded in a 5#-3# orientation, resulting in a labeled
ononucleotide. Thus, processing efficiency for this
ubstrate is measured by gradual disappearance of the
ubstrate and accumulation of mononucleotides (Fig-
re 2A, lane 2). Processing was abolished by the αMa
nd was unaffected by a control oligonucleotide (αD)
omplementary to the first 17 nucleotides of the Dro-
ophila U7 snRNA (lanes 3 and 4). In spite of processing
f 85% of the input pre-mRNA, UV irradiation did not
enerate any RNA-protein crosslink that was depen-
ent on U7 snRNP (data not shown).
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39Figure 2. 3# End Processing and UV Crosslinking Using the Full-Length RNA Substrates
(A) Left panel: diagram of construction of the full-length (FL) substrate with a radiolabeled phosphate (asterisk) at the cleavage site. Only
partial sequences of the SL and DCP RNAs are shown. The first and the fifth nucleotides after the stem are indicated with numbers. Right
panel: in vitro processing of the gel-purified FL pre-mRNA in Mm NE (lanes 2–4) in the presence of the indicated amounts (pmol) of compet-
itors.
(B) Left panel: diagram of construction of the FL(1S) RNA containing the phosphorothioate modification (S) at the cleavage site and a
radiolabeled phosphate (asterisk) 1 nucleotide upstream. Right panel: in vitro processing of the FL(1S) RNA in Mm NE (lanes 3–6) in the
presence of the indicated amounts (pmol) of competitors. The 5#-labeled DCP+1/S used in RNA ligation is shown in lane 1 and the FL(1S)
substrate in lane 2.
(C) High-resolution gel electrophoresis of processing products of the site-specifically labeled FL(1S) RNA generated in a mouse NE (lanes 2
and 4). The 5#-labeled DCP+1/S (lane 1) and SL RNAs (lane 3) are used as size standards.
(D) Left panel: high-resolution gel electrophoresis of processing products of the 5#-labeled FL (lane 2) and FL(1S) RNAs (lane 3) generated in
a mouse NE. The 5#-labeled SL and SL−1 (lanes 1 and 4) were used as size standards. Right panel: the position of the cleavage sites in the
FL(1S) RNA.
(E) Processing (left panel) and UV crosslinking (right panel) using the FL(1S) RNA. The numbers in parentheses above each lane indicate the
amounts of each competitor in pmol (lanes 2–5). The RS RNA is the reverse stem mutant of the SL RNA unable to bind SLBP. The specific
crosslinks, which correlate with processing, are indicated with arrows (right panel).Processing and UV Crosslinking Using the Full-
Length Substrate Containing a Phosphorothioate
One possible explanation for the failure to detect any
U7-dependent crosslinks on the FL RNA could have
been the rapid rate of the catalysis. To overcome this
potential limitation, the scissile bond was changed by
introduction of a phosphorothioate, a modification that
increases resistance of nucleic acids to nucleases
(Koziolkiewicz et al., 1997). We reasoned that this modi-
fication might slow down the kinetics of the cleavage
reaction, thus providing a sufficient time window to
crosslink the endonuclease while it was in contact with
the RNA. To place the phosphorothioate at the scissile
bond, the DCP was extended at the 5# end by an aden-
osine, and the modification (S) was introduced within
the first phosphodiester bond (Figure 2B). To empha-
size extension of the typical downstream cleavage
product by 1 nucleotide and the presence of 1 phos-phorothioate, we refer to this RNA as DCP+1/S. The
5#-labeled DCP+1/S RNA was ligated to the stem-loop
fragment lacking the last nucleotide (SL−1). In the li-
gated FL(1S) RNA, the phosphorothioate modification
was at the cleavage site, and the radioactive phosphate
was 1 nucleotide upstream, between a cytosine and an
adenosine. Processing of the gel-purified FL(1S) gener-
ated a major product that contained the radioactive
phosphate and had the mobility of the SL RNA (Figure
2B, lane 3), thus suggesting that cleavage predomi-
nantly occurred either at the regular cleavage site or
slightly further downstream. There was also a small
amount of a product comigrating with the DCP+1/S, in-
dicating that the presence of the phosphorothioate re-
sulted in generation of a minor cleavage site upstream
of the normal cleavage site, leaving the label on the
DCP. Generation of both products was nearly com-
pletely inhibited in the presence of 30 pmol of the αMa
Cell
40oligonucleotide, whereas the αDa had no effect (Figure
2B, lanes 4 and 5). The SL competitor reduced process-
ing at the major cleavage site from 75% to about 40%
and had no detectable effect on processing at the mi-
nor site (lane 6).
To precisely map the sites of cleavage in the FL(1S)
RNA, the processing products were separated on a
high-resolution polyacrylamide gel next to the SL,
SL−1, and DCP+1/S labeled at the 5# end. The less
abundant processing product comigrated with the
DCP+1/S (note that both RNAs contain a labeled phos-
phate at the 5# end), demonstrating that the minor
cleavage site is located 1 nucleotide upstream of the
regular cleavage site, between the cytidine and adeno-
sine (Figure 2C, lanes 1 and 2). The major cleavage
product (containing the internal radioactive phosphate
and no phosphate at the 5# end) migrated slightly more
slowly than the SL (lanes 2–4), and this difference is
either due to the lack of the 5# phosphate (Sollner-
Webb et al., 2001) or to cleavage occurring 1 nucleotide
downstream of the regular cleavage site. Importantly,
the latter possibility would indicate that the presence
of phosphorothioate at the normal cleavage site re-
sulted in the shifting of the cleavage 1 nucleotide in
either direction. To discriminate between these two
possibilities, we generated an unlabeled FL(1S) RNA by
ligating the SL−1 and the 5#-phosphorylated DCP+1/S.
As a control, we also generated an unlabeled FL RNA
lacking the phosphorothioate by ligating the SL and the
5#-phosphorylated DCP. Both RNAs were labeled at the
5# end, and their processing products were separated
on a high-resolution gel. Consistent with previous re-
sults, the control FL RNA was cleaved only at the nor-
mal site generating the upstream product comigrating
with the 5#-labeled SL (Figure 2D, lanes 1 and 2). As
expected from the previous analysis, the FL(1S) RNA
containing the modification was cleaved at two sites.
The major product had the same mobility as the SL,
and the minor product was 1 nucleotide shorter, comi-
grating with the 5#-labeled SL−1 (Figure 2D, lanes 3 and
4). We conclude from these experiments that the FL(1S)
containing the phosphorothioate in the cleavage site is
processed with about 70% efficiency at this site, al-
though the presence of the modification results in
cleavage of 30% of the substrate 1 nucleotide up-
stream (Figure 2D, right).
We next tested the ability of the FL(1S) RNA to form
processing-dependent RNA-protein crosslinks. To avoid
removal of the radioactive phosphate from proteins
crosslinked to the RNA, prior to separating on an SDS
gel, the UV-irradiated processing reactions were treated
with RNase T1, cleaving after guanosines, instead of
RNase A, which cleaves after pyrimidines and might re-
move the label from the adenosine crosslinked to the
protein. Three RNA-protein crosslinks migrating at 45,
52, and 85 kDa (Figure 2E, right, arrows) were gener-
ated in a control processing reaction, and none of the
crosslinks were affected by control oligonucleotides
unable to bind the mouse U7 snRNA (αD, lane 3) or
SLBP (RS, lane 5). Excess SL eliminated formation of
the two major bands migrating at 45 and 52 kDa, indi-
cating that they likely represent crosslinked SLBP (Fig-
ure 2E, right-hand panel, lane 4). Importantly, there was
a less intense crosslink migrating at 85 kDa, formation
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sf which was abolished by the αMa and significantly
educed by the presence of the SL (Figure 2E, right,
anes 2 and 4), thus demonstrating the correlation be-
ween crosslinking and processing expected for the
leavage factor (Figure 2E, left).
V Crosslinking to the FL(1S) and DCP+1/S
NAs and Preliminary Characterization
f the 85 kDa Crosslink
he HDE from the H2A-614 pre-mRNA can efficiently
ind the U7 snRNP in the absence the stem loop and
LBP (Dominski et al., 1999). Therefore, we compared
he pattern of crosslinking with the DCP+1/S labeled at
he 5# end to that seen with the FL(1S) RNA. A labeled
ononucleotide was rapidly released from the DCP+1/S
NA incubated in a mouse nuclear extract, and the re-
ction required U7 snRNP since it was completely in-
ibited by the αMa but unaffected by the αD (Figure 3A,
eft-hand panel, lanes 1–3). The FL(1S) RNA gave the
ame two cleavage products observed in Figure 2Bigure 3. UV Crosslinking to the FL(1S) and DCP+1/S RNAs and
reliminary Characterization of the 85 kDa Crosslink
A) Formation of processing products (left) and crosslinks (right)
sing DCP+1/S (lanes 1–3) or FL(1S) RNAs (lanes 4–6) as substrates
n Mm NE. The numbers in parentheses indicate amounts of each
ompetitor in pmol. Note that the order of samples in the right
anel has been switched in lanes 5 and 6.
B) U7-dependent release of the 5#-labeled mononucleotide (top)
nd crosslink formation (bottom) using DCP+1/S (lanes 1–3) or mu-
ant mDCP+1/S (lanes 4–6) as substrates in Mm NE in the presence
f the indicated competitors.
C) U7-dependent release of the 5#-labeled mononucleotide (top)
nd crosslink formation (bottom) using DCP+1/S (lanes 1–3) or
CP+1 lacking the phosphorothioate (lanes 4–6) as substrate in
m NE in the presence of the indicated competitors.
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41(Figure 3A, left-hand panel, lanes 4–6). After UV irradia-
tion and RNase T1 treatment, the processing reactions
were analyzed for generation of RNA-protein cross-
links. Two crosslinks were detected with the DCP+1/S
substrate: a U7-dependent 85 kDa protein that comi-
grated with the 85 kDa crosslink formed on the FL(1S)
RNA and a new crosslink that migrated at about 50
kDa, just below the major stem-loop-dependent cross-
link formed on the FL(1S) RNA (Figure 3A, right-hand
panel). The 50 kDa crosslink was not affected by the
presence of either the αMa or αD oligonucleotides,
whereas the 85 kDa crosslink was abolished by the αMa.
Since the 5#-labeled DCP+1/S was readily available
in large quantities, we used this substrate to further
characterize the UV-crosslinked proteins. In contrast to
the FL(1S) RNA, in which the radioactive phosphate is
preceded by a cytosine, the DCP+1/S contains the ra-
dioactive phosphate on the first nucleotide, an adeno-
sine, and thus it can be digested with RNase A without
risk of removing the label from the crosslinked proteins.
Indeed, the same two protein crosslinks of 85 kDa and
50 kDa were detected with the DCP+1/S substrate
when RNase A was used instead of RNase T1 (see Fig-
ure S1A in the Supplemental Data available with this
article online). A nuclear extract from HeLa cells was
also capable of forming the 85 kDa crosslink with the
DCP+1/S, although its efficiency was much lower than
for mouse nuclear extracts. This lower efficiency of
crosslinking of the 85 kDa protein correlated with much
lower activity of HeLa nuclear extracts in releasing the
radioactive mononucleotide from the DCP+1/S (Figure
S1B). Detection of the 85 kDa crosslink absolutely re-
quired a 5–10 min preincubation of samples at 32°C,
whereas subsequent UV irradiation could be carried
with the same result at either room temperature or on
ice (Figure S1C).
To further demonstrate that crosslinking of the 85
kDa protein depends on binding of U7 snRNP, we used
a mutant RNA substrate unable to form a strong duplex
with U7 snRNA. We mutated the purine core AAGA in
the DCP+1/S (Figure 1A, nucleotides 2–5 of the HDE) to
UUCA, thus significantly limiting the base-pairing po-
tential between the RNA substrate and the U7 snRNA.
The mDCP+1/S mutant RNA labeled at the 5# end was
stable in a mouse nuclear extract (Figure 3B, top, lanes
4–6) and formed only the 50 kDa crosslink and not the
85 kDa crosslink, emphasizing the importance of the
interaction between the RNA substrate and the U7
snRNP for recruitment of the 85 kDa protein and release
of the labeled mononucleotide (Figure 3B, bottom,
lanes 4–6). To prove that generation of the 85 kDa pro-
tein crosslink was due to introduction of the phos-
phorothioate, we used an RNA substrate of the same
length and sequence as the DCP+1/S but lacking the
phosphorothioate modification (DCP+1). The radioac-
tive label was efficiently removed from the 5# end of the
DCP+1 RNA substrate during the 90 min incubation in
a mouse nuclear extract, but only the 50 kDa protein
crosslink was detected (Figure 3C, lanes 4–6). Based
on this result, we conclude that the presence of the
phosphorothioate modification is a prerequisite for effi-
cient crosslinking of the 85 kDa protein.Specificity of UV Crosslinking to the DCP+1/S
We used various RNA and 2#-O-methyl competitors to
test the correlation between formation of the 85 kDa
and 50 kDa crosslinks and release of the 5#-labeled
adenosine from the DCP+1/S RNA. In addition to the
αMa, we used αHDEa, a 2#-O-methyl oligonucleotide
complementary to 16 nucleotides of the HDE (Figure
1A). Removal of the labeled mononucleotide from the
DCP+1/S RNA as well as formation of both the 85 and
50 kDa crosslinks was abolished in the presence of 10
pmol of the HDEa, a 100-fold molar excess over the
substrate (Figure 4A, lane 2). None of the nonspecific
RNA competitors, used in amounts ranging from 15 to
300 pmol, including the SL RNA, the RS RNA, and a 20-
mer 2#-O-methyl oligonucleotide complementary to the
Drosophila U7 snRNA (αDb), had any effect on either
the release of the labeled mononucleotide from the
DCP+1/S or formation of the 85 and 50 kDa crosslinks
(Figure 4A, lanes 3–8). Note that excess of the SL RNA
had no effect on crosslinking of the 85 kDa protein to
the DCP+1/S RNA, although it had a significant effect
on formation of the same crosslink on the full-length RNA
FL(1S) (Figure 2E, right-hand panel). This result is consis-
tent with the lack of the stem loop in the DCP+1/S sub-
strate and the release of the labeled mononucleotide
occurring in an SLBP-independent manner.
We also tested the effect of two shorter 2#-O-methyl
oligonucleotides: αMb, complementary to 11 nucleo-
tides of the mouse U7 snRNA, and αHDEb, comple-
mentary to 10 nucleotides of the HDE (Figures 1A and
1B). The αMb at 40 and 4 pmol was a very potent inhibi-
tor of the RNA processing and formation of the cross-
link to the 85 kDa protein (Figure 4B, lanes 2 and 3;
Figure 5C, lane 2) and at 0.4 pmol was partially effective
(Figure 4B, lane 4; Figure 5C, lane 3). The αHDEb at 20
pmol almost entirely blocked release of the 5#-labeled
adenosine and crosslinking of the 85 kDa and 50 kDa
proteins, while 2 pmol had a moderate effect (Figure
4B, lanes 5 and 6). The release of the mononucleotide
from the DCP+1/S RNA and crosslinking of the 85 kDa
protein were abolished by the excess of the unlabeled
substrate, confirming that the nuclease cleaving off the
5# adenosine depends on a limiting factor, most likely
the U7 snRNP (lanes 8–10). Consistent with this, 200
pmol of the mDCP+1/S RNA, more than a 1000-fold ex-
cess over the labeled RNA, did not reduce the amount
of the mononucleotide and formation of the 85 kDa
crosslink, although crosslinking of the 50 kDa protein
was abolished (Figure 4C, lane 5). Clearly, the interac-
tion of the 50 kDa protein with the substrate is not re-
quired for release of the mononucleotide from the
DCP+1/S RNA. We also tested as competitors a num-
ber of previously characterized full-length pre-mRNAs
consisting of the stem loop and different HDE se-
quences. Two of these substrates, Drosophila-specific
H3 pre-mRNA and HDE− mutant of the H2A pre-mRNA,
are not processed in mammalian extracts since they
do not interact stably with the U7 snRNP, and the third
substrate, the mouse H1t pre-mRNA, is processed
poorly due to weak binding of the U7 snRNP (Dominski
et al., 1999). The wild-type H2A-614 pre-mRNA at a 25-
fold molar excess over the labeled RNA substrate
nearly completely abolished processing and generation
of the 85 kDa crosslink (Figure 4C, lane 7). The three
Cell
42Figure 4. Specificity of UV Crosslinking to the
DCP+1/S
(A–C) Effects of various competitors indi-
cated at the top of each lane on release of
the 5#-labeled mononucleotide (top) and
crosslink formation (bottom) in Mm NE using
the DCP+1/S RNA as a substrate. Numbers
in parentheses indicate the amount of the
RNA competitors in pmol.
(D) Effects of NP-40 on release of the
5#-labeled mononucleotide (top) and cross-
link formation (bottom) in Mm NE using the
DCP+1/S RNA as a substrate.
(E) Northern blot analysis of the mouse U7
snRNA in processing complexes formed in
either the absence (lane 1) or presence of the
H2A-614 pre-mRNA (lanes 2 and 3). Process-
ing complexes were precipitated by anti-SLBP
and collected on protein A agarose beads in
either the absence (lane 2) or presence of
0.1% NP-40 (lane 3), and the amount of U7
snRNA was determined by Northern blotting.remaining RNAs, the H1t, the Drosophila H3, and the
HDE− mutant, at the same molar concentration had no
effect on processing and crosslinking (Figure 4C, lanes
8–10). Taken together, these results clearly demonstrate
that formation of the 85 kDa crosslink is dependent on
the ability of the substrate to efficiently bind the U7
snRNP.
We have observed that increasing the concentrations
of NP-40 over 0.025% abolished processing of the
H2A-614 pre-mRNA, although 0.01% NP-40 had no ef-
fect (data not shown). Interestingly, concentration as
high as 0.1% does not affect the amount of the U7
snRNA detected in processing complexes assembled
on the H2A-614 pre-mRNA (Figure 4E, lanes 2 and 3),
suggesting that NP-40 interferes with a step other than
the binding of the U7 snRNP. We tested effects of
0.01% and 0.05% NP-40 on degradation of the DCP+1/S
RNA and crosslinking of the 85 kDa protein. While the
release of the mononucleotide from the DCP+1/S and
crosslinking of the 85 kDa protein were not affected in
the presence of 0.01% NP-40, both events were fully
inhibited by 0.05% NP-40 (Figure 4D, lanes 2 and 3).
Therefore, it is likely that NP-40 may have a direct effect
on recruiting the 85 kDa protein to the DCP+1/S by the
U7 snRNP stably associated with the RNA. Alterna-
tively, NP-40 causes dissociation of a loosely associ-
ated component from the U7 snRNP that is required for
recruitment of the 85 kDa protein.
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3istinguishing between the Endonucleolytic
nd the 5-3 Exonucleolytic Activities
wo different mechanisms, leading to the same prod-
ct, could be responsible for the release of the radioac-
ive 5# nucleotide from the DCP+1/S RNA: a 5#-3# exo-
ucleolytic degradation or an endonucleolytic cleavage
ollowed by the 5# exonucleolytic degradation of the
CP, as in the case of natural histone pre-mRNAs.
ince it is not possible to discriminate between these
wo mechanisms using the DCP+1/S RNA, we used two
ther RNA substrates in which the DCP sequence was
xtended at the 5# end by either 5 (DCP+5/S) or 6 nu-
leotides (DCP+6/5S) preceding the normal cleavage
ite (Figure 5A). The DCP+5/S RNA contained the phos-
horothioate modification at the normal cleavage site
etween an adenosine and cytidine, while DCP+6/5S
ad four additional phosphorothioates, two on each
ide of the cleavage site. When these RNA substrates
abeled at the 5# end were incubated in a mouse
uclear extract, the same U7-dependent release of the
adioactive mononucleotide was observed as in the
ase of the DCP+1/S (Figure 5B). The reaction occurs
n the presence of EDTA, which stabilizes the upstream
leavage product, thus making it unlikely that the
DC+5/S and DCP+6/5S are endonucleolytically cleaved
urther away from the 5# end followed by degrading the
esultant upstream product to mononucleotides by a
#-5# exonuclease. This result demonstrates that mov-
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(A) Partial sequences of the DCP+5/S and DCP+6/5S RNAs beginning with the most 5# nucleotide. Phosphorothioate-modified bonds are
indicated with S. Sites of the expected endonucleolytic cleavage (used in the full-length RNAs) and initial 5# exonucleolytic attack are
indicated with arrows. The labeled phosphate is represented by an asterisk.
(B) Release of the labeled mononucleotide from the 5#-labeled DCP+5/S (lanes 1–3) and DCP+6/5S RNAs (lane 4–6) in Mm NE. The numbers
in parentheses indicate the amount of the RNA competitors in pmol.
(C) High-resolution gel electrophoresis of labeled mononucleotides released upon incubation of the indicated RNAs with S1 nuclease (lanes
1 and 5) or Mm NE (lanes 2–4).
(D) Diagram of construction of the FL(5S) RNA containing a radiolabeled phosphate (asterisk) within the stem and five phosphorothioate
modifications (S) around the cleavage site. Only partial sequences of the SL-6 and DCP+6/5S RNAs used in ligation are shown. The nucleo-
tides in the FL(5S) following the stem are numbered.
(E) In vitro processing of the FL(5S) RNA in Mm NE (lanes 2–8) in the presence of the indicated amounts (pmol) of competitors.
(F) Formation of UV crosslinks in the processing reactions shown in (E). Processing-dependent crosslinks are indicated with arrows.ing the 5# end further away from the HDE does not pre-
vent the exonucleolytic activity dependent on the U7
snRNP and strongly suggests that the first nucleotide
of DCP+1/S RNA is also removed by an exonucleolytic
activity. The labeled mononucleotides released from
the DCP+5/S and DCP+6/5S comigrated in a 14% high-
resolution gel with the mononucleotides released after
complete digestion of the two RNAs by S1 nuclease
(Figure 5C), indicating that they contain a 3# hydroxyl
group (Sollner-Webb et al., 2001).
Cleaving of the FL(1S) RNA at the minor site 1 nucleo-
tide upstream of the normal site containing the phos-
phorothioate generated 5#-labeled DCP+1/S, which
was subsequently converted with about 50% efficiency
into mononucleotides (Figure 2E). This raised a possi-
bility that the 85 kDa crosslink was not formed during
contact with the full-length RNA but instead was only
formed after cleavage, during the degradation of the
DCP+1/S, as observed in the case of the synthetic
DCP+1/S RNA. Although this possibility seemed un-
likely given the low efficiency of this pathway, we con-
structed a new full-length RNA by ligating the 5#-
labeled DCP+6/5S with the SL lacking 6 nucleotides
from the 3# end (Figure 5D). In the FL(5S) RNA, the ra-dioactive phosphate was placed within the stem, thus
precluding any upstream cleavage that would have re-
sulted in generation of a labeled downstream cleavage
product. The purpose of the five phosphorothioate
modifications was to allow detection of the crosslink in
any possible cleavage site, which might be shifted 1 to
2 nucleotides in each direction.
The gel purified FL(5S) was efficiently cleaved in a
mouse nuclear extract giving rise to two closely migrat-
ing upstream products (detectable with this substrate
due to upstream position of the label), with the upper
band being predominant (Figure 5E). In a high-resolu-
tion gel, the upper product comigrated with the major
cleavage product of the site-specifically labeled FL(1S)
RNA, and the minor product was 1 nucleotide shorter
(data not shown). Thus, the FL(5S) RNA is cleaved at
the same sites as the FL(1S). The processing was de-
pendent on U7 snRNP and was competed by 100-fold
molar excess of unlabeled DCP+1/S but not by the mu-
tant version unable to bind U7 snRNP (Figure 5E, lanes
7 and 8). As expected, excess of the SL RNA reduced
the efficiency of processing, and the RS had no effect
(lanes 5 and 6). When the same processing reactions
were UV irradiated and treated with RNase T1, the pat-
Cell
44tern of crosslinked proteins looked very similar to that
obtained with the FL(1S) RNA (Figure 5F). The main dif-
ference was that there was a doublet near 85 kDa rather
than a single band (Figure 5F). The lower band comi-
grated with the 85 kDa crosslink formed on the DCP+1/S
RNA (data not shown), whereas the more intense band
had slightly lower mobility. Formation of this doublet
crosslink correlated with processing efficiencies and
responded to all competitors in the same manner as
formation of the 85 kDa crosslink on the FL(1S) RNA
(Figure 5F). Processing and formation of the doublet
crosslink, but not stem-loop-dependent crosslinks,
were also abolished by the presence of 0.05% NP-40
or 100-fold excess of the αHDEa blocking the U7 bind-
ing site (data not shown). This analysis suggested that
the doublet may represent the same 85 kDa protein
with the upper crosslink bound to a larger portion of
the RNA due to incomplete digestion with RNase T1.
Immunoprecipitation of Crosslinked Proteins
Our studies demonstrated that the 85 kDa protein in-
teracts with both the full-length histone pre-mRNA and
the downstream cleavage product in a U7-dependent
manner. The electrophoretic mobility of the 85 kDa pro-
tein indicated that this is a new factor in histone-pre-
mRNA processing. To identify the 85 kDa protein, we
initially used crosslinks formed on the DCP+1/S RNA
due to its availability in large quantities and tested a
number of antibodies against known proteins. We re-
cently characterized a potential candidate for the endo-
nuclease in 3# end processing of histone pre-mRNAs
as a heterodimer of RC-68 and RC-74 (Dominski et al.,
2005), two proteins highly similar to CPSF-73 and
CPSF-100. While RC-68 migrates at about 63 kDa, RC-
74 has a mobility identical to the 85 kDa crosslink. We
used an antibody against the C-terminal peptide of RC-
74 and carried out immunoprecipitation under denatur-
ing conditions. In this method, the sample containing
the crosslinked proteins is treated with an RNase,
boiled in the presence of 1% SDS, and then diluted
10-fold prior to addition of an antibody. This approach
increases the efficiency of immunoprecipitation when
the protein of interest is imbedded in a larger complex
and therefore is not accessible to the antibody in a na-
tive form. The RC-74 antibody efficiently precipitated
denatured RC-74, as determined by Western blotting,
but did not precipitate any of the radioactive 85 kDa
protein, demonstrating that the 85 kDa protein is not
RC-74 (data not shown).
We next considered the possibility that the 85 kDa
protein might be CPSF-73, the suspected cleavage fac-
tor in cleavage/polyadenylation, which also migrates on
SDS gels near 85 kDa (Dominski et al., 2005). As deter-
mined by IP/Western, an αCPSF-73 antibody (kindly
provided by Dr. W. Keller, University of Basel) was un-
able to precipitate CPSF-73 from a native nuclear ex-
tract (data not shown) but efficiently precipitated
CPSF-73 from an extract denatured by boiling in the
presence of SDS (Figure 6A, bottom panel, lanes 9 and
13). The αCPSF-73 antibody incubated with a UV-irradi-
ated and denatured processing reaction containing the
DCP+1/S RNA selectively precipitated the 85 kDa but
not the 50 kDa protein, thus identifying the 85 kDa pro-
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wigure 6. Immunoprecipitation of UV-Crosslinked Proteins
A) Processing reactions containing the 5#-labeled DCP+1/S RNA
ere UV irradiated, treated with RNase A, denatured by boiling in
he presence of SDS, and incubated with antibodies indicated at
he top of each lane. The reactions were prepared either in the
bsence (No αMb) or presence of the αMb (+ αMb). The precipi-
ated proteins were resolved in SDS gels and detected by autoradi-
graphy. The immunoprecipitation of CPSF-73 in samples shown
n lanes 7–14 was monitored in parallel by Western blotting using
CPSF-73 (bottom panel). The position of the immunoglobulin
eavy chain is indicated with HC.
B and C) Processing reactions containing the site-specifically la-
eled FL(1S) (B) or FL(5S) RNAs (C) were prepared and processed
s described in (A), with the exception that RNase T1 was used
nstead of RNase A. Note that the gel in (C) was run longer than
ther gels in (A) and (B), accounting for the larger distance between
he 93 and 52 kDa size markers.ein as CPSF-73 (Figure 6A, lane 3). Quantification of
he data on a PhosphorImager demonstrated that over
5% of the input 85 kDa crosslink was precipitated with
he αCPSF-73. The two control antibodies directed
gainst RC-74 and RC-68 did not precipitate any la-
eled proteins (Figure 6A, lanes 2 and 4). We also ana-
yzed a processing reaction prepared in the presence
f the αMa oligonucleotide, which prevented formation
f the 85 kDa UV crosslink but did not reduce the inten-
ity of the 50 kDa band or the background (Figure 6A,
ane 5). The αCPSF-73 antibody did not precipitate any
adioactive protein from this sample (lane 6).
We repeated the above experiment using a different
abbit antibody against CPSF-73 (αCPSF-73b), kindly
rovided by Dr. D. Bentley (University of Colorado, Den-
er). We prepared a large-scale processing reaction
ith the DCP+1/S RNA either without (lanes 7–10) or
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45with the αMa oligonucleotide (lanes 11–14) and tested
the αCPSF-73b antibody in parallel with the initial
αCPSF-73. The results from these experiments were
the same as described above: each of the two antibod-
ies directed against CPSF-73 selectively precipitated
the 85 kDa radioactive protein from the control pro-
cessing reaction (Figure 6A, top, lanes 9 and 10), while
the αRC-74 was unable to precipitate any radioactive
protein (lane 8). The two αCPSF-73 antibodies did not
precipitate any radioactive protein from processing re-
actions containing the αMa (lanes 13 and 14), although
they efficiently precipitated CPSF-73 from aliquots of
the same processing reactions, as determined by West-
ern blotting (Figure 6A, lanes 13 and 14, bottom).
Finally, following the same denaturing protocol as
that used for the DCP+1/S RNA, we determined that
CPSF-73 was also crosslinked to the full-length sub-
strates. To prevent removal of the label from cross-
linked proteins, RNase T1 was used instead of RNase
A. The αCPSF-73 antibody identified the 85 kDa protein
crosslinked to the FL+1/S RNA as CPSF-73 (Figure 6B,
lane 4), and the αSLBP antibody identified two cross-
links at 45 and 52 kDa as SLBP (Figure 6B, lane 3).
While the 45 kDa crosslink migrates at position typical
of SLBP, the slower form is most likely attached to a
larger portion of the RNA protected against RNase T1
digestion by binding of SLBP. An antibody directed
against the C-terminal peptide of 3#hExo, a 3# exo-
nuclease that specifically binds to the downstream side
of the stem loop in the histone mRNA but not to the
pre-mRNA (Dominski et al., 2003), did not precipitate
any crosslinked protein (Figure 6B, lane 2). The αCPSF-
73 antibody also precipitated the two crosslinks migrat-
ing at about 85 kDa formed in a processing-dependent
manner on the FL(5S) RNA (Figure 6C, lanes 1 and 2).
Thus, formation of the doublet was a result of the
crosslinking of CPSF-73 to the RNA substrate followed
by its incomplete digestion with RNase T1. In conclu-
sion, we identified the 85 kDa protein crosslinked in a
U7-dependent manner to the histone pre-mRNA and to
the downstream cleavage product as CPSF-73, an
essential component of the cleavage/polyadenylation
apparatus.
Discussion
Histone-pre-mRNA processing requires binding of the
U7 snRNP to the HDE located 12–15 nucleotides 3# of
the cleavage site. The U7 snRNP plays the key role in
assembling the processing complex and functions as
a molecular ruler directing the cleavage factor to the
appropriate phosphodiester bond in the pre-mRNA
(Scharl and Steitz, 1994). Two reactions are catalyzed
by the processing complex containing the U7 snRNP:
an endonucleolytic cleavage of histone pre-mRNA to
form the 3# end of histone mRNA and a 5#-to-3# exo-
nucleolytic degradation of the downstream cleavage
product, which may play a role in recycling the U7
snRNP (Walther et al., 1998). In this study, we identified
a protein of 85 kDa that crosslinks in a U7-dependent
manner to the RNA substrates during both endonucleo-
lytic cleavage and 5#-to-3# exonucleolytic degradation.
Immunoprecipitation experiments identified this proteinas CPSF-73, a component of the cleavage/polyadeny-
lation machinery recently proposed to function as the
cleavage factor in formation of the polyadenylated
mRNAs (Aravind, 1999; Callebaut et al., 2002; Ryan et
al., 2004).
UV Crosslinking of CPSF-73 to the RNA
Substrates Is Processing Dependent
We used two different 2#-O-methyl oligonucleotides
complementary to the 5# end of the mouse U7 snRNA,
αMa and αMb, that specifically inhibit endonucleolytic
cleavage of the full-length pre-mRNAs, FL(1S) and
FL(5S), and 5#-3# exonucleolytic degradation of the
downstream cleavage product, DCP+1/S. Both oligo-
nucleotides abolished UV crosslinking of CPSF-73 to
these RNA substrates. The cleavage and degradation
as well as crosslinking of CPSF-73 were also abolished
by an excess of RNA containing the wild-type U7 bind-
ing site but not with RNAs unable to efficiently interact
with the U7 snRNP. In addition to crosslinking of CPSF-
73, we also detected crosslinking of SLBP to the full-
length substrates and a 50 kDa protein to the DCP+1/S
RNA. As expected, binding of SLBP to the full-length
RNA was not inhibited by the addition of the αMa since
SLBP interacts with the stem loop independently of U7
snRNP. We have previously demonstrated that SLBP
stimulates binding of the U7 snRNP to the pre-mRNA
and increases the efficiency of processing (Dominski et
al., 1999). Consistent with these studies, sequestering
SLBP reduced processing and crosslinking of CPSF-73.
The competition experiments suggested that the 50
kDa protein is not essential for degradation of the
DCP+1/S RNA. However, coprecipitation of the 50 kDa
crosslink by the anti-Sm antibody suggests that it may
be a part of a larger complex with the U7 snRNP or
another Sm-precipitable particle (Figure S2). Additional
studies are required to determine the identity and the
relevance, if any, of this protein to 3# end processing of
histone pre-mRNAs.
The key modification that allowed UV crosslinking of
CPSF-73 was incorporation of a phosphorothioate at
the cleavage site in the full-length RNA or near the 5#
end of the DCP. RNA substrates lacking this modifica-
tion, in spite of undergoing very rapid processing, did
not crosslink to any protein in a processing-specific
manner. Introduction of a single phosphorothioate did
not significantly reduce the overall efficiency of pro-
cessing or degradation, which is probably limited by
the rate of assembly of the U7 snRNP and other neces-
sary factors on the RNA substrate. However, this modi-
fication likely slowed down the rate of the nucleolytic
attack, allowing CPSF-73 to stay longer in contact with
the RNA. The presence of the phosphorothioate in the
cleavage site in the full-length RNA did not prevent pro-
cessing in this site, although it resulted in generation of
a minor cleavage site 1 nucleotide upstream, indicating
that this modification creates an at least partially unfa-
vorable context for processing.
CPSF-73 Is a Primary Candidate for 3
Endonuclease in Formation of Histone
RNAs and Polyadenylated mRNAs
Crosslinking of CPSF-73 only in the presence of the
phosphorothioate modification in RNA substrates, in-
Cell
46Figure 7. 3# End Processing of Histone Pre-
mRNAs
Components of the 3# end-processing ma-
chinery cleaving histone pre-mRNAs and
known or predicted interactions within the
complex. Lsm10 in the unique U7 Sm core
complex is not indicated. The complex may
contain other proteins, possibly CPSF-100
(not shown).dicative of the transient nature of the interaction,
strongly suggests CPSF-73 is the cleavage factor in 3#
end processing of histone pre-mRNAs. However, the ul-
timate proof of this function will require purification of
CPSF-73, and possibly auxiliary proteins, and direct
demonstration that it displays nucleolytic activity in vitro.
The role of CPSF-73 as the endonuclease in 3# end
processing in histone pre-mRNAs is supported by
structural features of this protein characterized by the
presence of the β-CASP domain typical of a small
group of proteins with either predicted or proven
nuclease activity (Callebaut et al., 2002). This group in-
cludes two DNA-specific nucleases: Artemis, involved
in V(D)J recombination and DNA double-strand break
repair (Moshous et al., 2001), and SNM1, involved in
DNA crosslink repair (Dronkert et al., 2000). Within
a small region flanking the catalytic histidine motif,
CPSF-73 is also similar to ELAC1 and ELAC2, two re-
lated endonucleases required for 3# end processing of
pre-tRNAs (Takaku et al., 2003). Notably, two β-CASP
domain proteins distantly related to CPSF-73 have re-
cently been identified in Bacillus. These proteins,
RNase J1 and J2, are involved in maturation of specific
mRNAs in vivo and display in vitro endonucleolytic ac-
tivity on RNA substrates (Even et al., 2005).
A growing amount of circumstantial evidence sug-
gests that CPSF-73 is the endonuclease in formation of
polyadenylated mRNAs. However, crosslinking experi-
ments with a site-specifically labeled pre-mRNA sub-
strate failed to detect this protein at the cleavage site
(Ryan et al., 2004). Despite using different sequence
elements and factors that recognize these elements, 3#
end processing of histone pre-mRNAs and cleavage
coupled to polyadenylation exhibit some striking sim-
ilarities. Both types of pre-mRNA contain two sequence
elements required for processing, and cleavage occurs
between the two sequence elements, preferentially af-
ter an adenosine. The precise position of the cleavage
site in both types of pre-mRNA is not absolute and can
be shifted to a less preferable nucleotide by changing
the spacing between the two elements (Chen et al.,
1995; Scharl and Steitz, 1994). Following the endo-
nucleolytic cleavage, the upstream fragment corres-
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ionds to the mature mRNA, whereas the downstream
ragment is converted into a group of truncated prod-
cts differing in location of the 5# end (Sheets et al.,
987; Walther et al., 1998). Finally, both processing re-
ctions are resistant to EDTA and generate a hydroxyl
roup at the 3# end typical of metal-mediated catalysis
Gick et al., 1986; Moore and Sharp, 1985; Wahle and
eller, 1996).
PSF-73 Is Likely Both the Endonuclease
nd 5-3 Exonuclease in 3 End Processing
PSF-73 crosslinked in a U7-dependent manner to
oth full-length RNAs and to the downstream cleavage
roduct. These results strongly suggest that CPSF-73
s both the endonuclease generating the correct 3# end
f histone mRNAs and the 5# exonuclease responsible
or release of the U7 snRNP. It is possible that the
#-to-3# mode requires the proximity of the 5# phos-
hate. It will be interesting to determine how long of an
xtension at the 5# end would still allow the 5#-3# activ-
ty to degrade the RNA. We predict that moving the 5#
nd sufficiently far away from the U7 binding site could
revent the exonucleolytic activity and result in switch-
ng to the endonucleolytic mode. Our interpretation that
PSF-73 carries both activities is supported by their
imilar reaction requirements. The cleavage of the FL
re-mRNA and the degradation of the DCP occur in the
resence of high concentrations of EDTA when most
uclear nucleases are inactive. In addition, both activi-
ies display similar sensitivity to low concentrations of
P-40 and increased concentrations of KCl (data not
hown). Interestingly, Artemis, a β-lactamase fold pro-
ein sharing the β-CASP domain with CPSF-73, in vitro
s a 5#-3# exonuclease and in complex with the DNA-
ependent protein kinase acts as endonuclease (Ma et
l., 2002). CPSF-73 may also require a second protein,
or example CPSF-100, to display its endonucleolytic
ctivity.
echanistic and Evolutionary Considerations
dentification of CPSF-73 as the likely endonuclease in
ormation of mature histone mRNAs raises a number of
mportant questions. How is CPSF-73 recruited to the
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47cleavage site by the two vastly different processing ma-
chineries, which do not share any other known factor
and assemble on the two vastly different pre-mRNA sub-
strates? In cleavage/polyadenylation, CPSF-73 is re-
cruited to the vicinity of the cleavage site by CPSF-160
that recognizes the AAUAAA. It is therefore unlikely that
CPSF-160 is involved in histone-pre-mRNA processing.
Indeed, crosslinking of CPSF-73 to the DCP+1/S or
FL(5S) was not competed by excess of an RNA contain-
ing the AAUAAA (Figure S3). CPSF-73 is most likely re-
cruited to the histone pre-mRNA by binding to a spe-
cific U7 snRNP protein, with two primary candidates
being either Lsm 11 or ZFP100 (Figure 7). CPSF-73 di-
rectly interacts with a related protein, CPSF-100, in
which the catalytic histidine motif is disrupted (Domin-
ski et al., 2005). It is possible that CPSF-100 is a media-
tor in recruiting CPSF-73 to the U7 snRNA and the
cleavage site.
The involvement of CPSF-73 in formation of the ma-
ture histone mRNAs and polyadenylated mRNAs may
suggest that the two 3# end processing mechanisms
are distantly related and evolved from common primor-
dial machinery. The most striking difference between
the two mechanisms is the requirement for an RNA-
containing factor in histone-pre-mRNA processing and
the lack of an RNA component in cleavage/polyadeny-
lation. Thus, 3# end processing of histone pre-mRNAs
may represent a more primitive reaction than cleavage
and polyadenylation, which may have evolved into an
entirely protein-based mechanism (Mowry and Steitz,
1988).
Experimental Procedures
RNAs
All RNA substrates used in crosslinking experiments and 2#-O-
methyl oligonucleotide competitors were synthesized by Dhar-
macon, and their sequences are shown in Figure 2. Full-length pre-
mRNA substrates were generated by T7 RNA transcription, gel
purified, and quantified.
RNA Labeling
Most RNA substrates were labeled at the 5# end using T4 poly-
nucleotide kinase (NEB) and 30 Ci of [γ-32P]ATP. Internally labeled
RNA substrates were synthesized by incorporation of [32P]αUTP in
the presence of T7 RNA polymerase, as described (Dominski et
al., 1999).
RNA Ligation
The site-specifically labeled full-length pre-mRNA substrate was
generated by joining two RNA segments, essentially as described
(Moore and Query, 2000).
Preparation of Nuclear Extracts
Nuclear extracts from mouse myeloma and HeLa cells grown at
the National Cell Culture Center (Minneapolis) were prepared as
previously described (Dominski et al., 1999).
UV Crosslinking
Each reaction used in crosslinking experiments was set up on ice
in a final volume of 20 l and contained the following: 0.1 pmol of
labeled RNA, 20 mM EDTA, 5 g of yeast tRNA, and 15 l of a
nuclear extract (w10 g protein/l). Unless otherwise indicated,
the samples were preincubated for 10 min at 32°C, and 15 l were
placed on parafilm and irradiated for 8 min at room temperature
with 1 J of UV (254 nm) from a distance of 2 in using UV Stratalinker
2400 (Stratagene). The remaining 5 l portion of each reaction was
incubated for an additional 80 min at 32°C and analyzed for pro-cessing efficiency by separating the reaction products in an 8%
polyacrylamide/7 M urea gel. Unless otherwise indicated, the UV-
irradiated samples containing the full-length RNA (FL), DCP+1/S,
or DCP+1 were treated with 20 g of RNase A. The samples con-
taining the FL(1S) and the FL(5S) were treated with 2000 units of
RNase T1 (Ambion). The samples treated with the appropriate
RNase were resolved in a 12% SDS-polyacrylamide gel and ana-
lyzed by autoradiography.
Detection of U7 snRNA
Formation and immunoprecipitation of processing complexes by
anti-SLBP in the absence or in the presence of 0.1% NP-40 and
detection of the mouse U7 snRNA by Northern blotting were car-
ried out as previously described (Dominski et al., 1999).
Immunoprecipitation
To immunoprecipitate denatured proteins, 25 l processing reac-
tions irradiated with UV were treated for 4 hr with either RNase A
or T1, mixed with the same volume of 2× SDS buffer (2% SDS, 20
mM Tris-HCl [pH 7.5]), and boiled for 5 min. The samples were
supplemented with 200 l of water and 250 l of 2× IP buffer (20
mM Tris [pH 7.5], 300 mM NaCl, 2 mM EDTA, 1% NP-40, 2% Triton
X-100) and used for immunoprecipitation with 2.5–5.0 l of appro-
priate antibody. The samples were rotated at 4°C for 18 hr and
subsequently transferred to new tubes containing 25 l of protein
A agarose beads. After 2.5 hr of rotation at 4°C, the beads were
collected by gentle centrifugation and washed several times with
1× IP buffer for a total of 1 hr. Proteins absorbed on the beads were
recovered by boiling with SDS loading dye and separated on 12%
SDS-polyacrylamide gels.
Supplemental Data
Supplemental Data include three figures and can be found with
this article online at http://www.cell.com/cgi/content/full/123/1/37/
DC1/.
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